Table 1 Subject demographic and clinical information

From: Characterizing brain dynamics during ketamine-induced dissociation and subsequent interactions with propofol using human intracranial neurophysiology

Subject ID

Gender

Age

Depth

Electrodes

Bipolar Channels

Baseline

Duration (s)

Ketamine Duration (s)

Propofol Duration (s)

Drugs Given During

General Anesthesia Period

1

F

59

10

55

366

840

NAa

Propofol, fentanyl, midazolam

2

M

22

11

57

370

739

164

Propofol, remifentanil, rocuronium

3

F

28

12

68

341

705

235

Propofol, fentanyl, rocuronium

4

M

22

10

60

307

850

NAa

Propofol

5

M

48

14

77

201

840

57

Propofol

6

F

34

9

65

300

840

402

Propofol (200 mg), fentanyl (100 mcg), rocuronium (30 mg), succinylcholine (100 mg)

7

F

22

10

104

300

840

50

Propofol (200 mg), fentanyl (100 mcg), midazolam (2 mg), rocuronium (40 mg), lidocaine (60 mg), vancomycin (1 g)

8

M

48

9

102

300

840

NAa

Propofol (200 mg), fentanyl (100 mcg), rocuronium (50 mg), lidocaine (80 mg), vancomycin (1 g), clindamycin (900 mg)

9

M

33

11

121

300

840

235

Propofol (200 mg), fentanyl (150 mcg), rocuronium (50 mg), lidocaine (80 mg), vancomycin (1250 mg)

10

F

43

10

115

300

840

445

Propofol (100 mg), rocuronium (50 mg)

  1. aWe did not collect the data for this patient because of limited time in the operating room. Dose information is not available for subjects #1-5. F female, M male, NA not available.